Intra-abdominal Fat Predicts Survival in Pancreatic Cancer
Background Body mass index (BMI) has proven unreliable in predicting survival following pancreaticoduodenectomy for cancer. While measures of intra-abdominal fat correlate with medical and postoperative complications of obesity, the impact of intra-abdominal fat on pancreatic cancer survival is unce...
Saved in:
Published in | Journal of gastrointestinal surgery Vol. 14; no. 11; pp. 1832 - 1837 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer-Verlag
01.11.2010
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Body mass index (BMI) has proven unreliable in predicting survival following pancreaticoduodenectomy for cancer. While measures of intra-abdominal fat correlate with medical and postoperative complications of obesity, the impact of intra-abdominal fat on pancreatic cancer survival is uncertain. We hypothesized that the quantity of intra-abdominal fat would predict survival following resection of pancreatic cancer.
Methods
Preoperative CT imaging was used to measure intra-abdominal fat. Cox regression analyses were used to identify independent predictors of survival.
Results
Sixty-one patients from 2000–2009 underwent pancreaticoduodenectomy for exocrine pancreatic adenocarcinoma. After adjusting for age and perineural invasion status, preoperative BMI did not predict overall survival (
p
< 0.827). Unlike BMI, quartile of intra-abdominal fat predicted survival. Relative to patients with the least intra-abdominal fat (lowest quartile), those with more intra-abdominal fat demonstrated worse overall survival, but in a non-linear fashion. Individuals in the second quartile showed a fourfold increase in likelihood of death (HR 4.018, 95% CI 1.099–14.687,
p
< 0.035) relative to the lowest quartile. Patients in the third (HR 2.124, 95% CI 0.278–16.222,
p
< 0.468) and fourth quartile (HR 1.354, 95% CI 0.296–6.190,
p
< 0.696) also showed greater risk of death.
Conclusions
Measuring intra-abdominal fat identifies a subset of patients with worse prognosis in pancreatic cancer. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1091-255X 1873-4626 |
DOI: | 10.1007/s11605-010-1297-5 |